Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec, InterMune Expand Research Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Evotec, InterMune Expand Research Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

InterMune, Inc. has signed its second drug discovery contract with Evotec AG under which Evotec will support InterMune’s research efforts with its medicinal chemistry expertise. Evotec will use its technologies in computational chemistry, protein production, X-Ray crystallography and ADMET to further characterize active compounds and optimize their potency and selectivity to generate lead molecules for advancement into clinical trials.
   
This contract expands the existing collaboration between the two companies and applies Evotec’s fragment-based drug discovery platform, EVOlution, in combination with its ultra-high-throughput screening (uHTS) technologies to InterMune’s targets. So far, new lead series have been identified for further optimization. The financial terms include a technology access fee for Evotec’s EVOlution discovery platform, as well as ongoing research funding.
   
“With the support of Evotec, InterMune has made considerable progress in their Hepatitis C drug discovery and development program. We are pleased that InterMune saw the value in our proprietary fragment-based drug discovery technology and that it has contributed to the success to their research efforts,” said Dr. Mark Ashton, executive vice president business development services at Evotec.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics